Apollo Hospitals has signed a memorandum of understanding (MOU) with Stanford University for the Stanford South Asian Translational Heart Initiative (SSAATHI) related to South Asians and Chronic Disease. Together, both parties will attempt to delve deeper into the causes associated with cardiovascular risk in diabetic and prediabetic South Asians. The MoU is the first step towards a long-term partnership that will develop and grow over time.
Conceptualized with the overall objective to reduce cardiovascular mortality in South Asians, the study will capture data on prediabetes and insulin resistance, help physicians understand early patterns of glycemic imbalance, help them understand the epigenetic impact on genetically similar populations, and achieve targeted lifestyle and medical therapy. The collaboration will at a later stage look at moving towards a larger Framingham type study that was developed with the objective of identifying common factors or characteristics contributing to chronic vascular diseases in Massachusetts.
Both the organizations are driven by the same objective of strengthening and broadening research on Non-Communicable Diseases (NCD’s), while also promoting the need for healthy living. Apollo’s rich experience in public health service and research expertise associated with guidance from Stanford will help physicians unravel more details on the NCD conundrum and devise necessary preventive interventions to deal with the same.
Apollo Hospitals is the leading private sector healthcare provider in Asia and owns and manages a network of speciality hospitals and clinics, a chain of Pharmacy retail outlets across the country, and provides Consultancy Services for commissioning and managing the Speciality Hospitals.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 7032.20 |
Max Healthcare Inst | 1149.45 |
Narayana Hrudayalay | 1311.85 |
Aster DM Healthcare | 503.80 |
Global Health | 1073.55 |
View more.. |